SNIBE(SZ:300832) Zheng Quan Shi Bao Wang·2025-08-25 10:40Core Insights - The company reported a slight decline in revenue and net profit for the first half of 2025, with revenue at 2.185 billion yuan, down 1.18% year-on-year, and net profit at 771 million yuan, down 14.62% year-on-year [1] Financial Performance - The basic earnings per share for the company stood at 0.9814 yuan [1] - The overall gross margin for the company was 68.64%, reflecting a decrease due to the growth in instrument revenue [1] Product Segment Analysis - The gross margin for instrument products was 26.16%, which is a decrease of 3.66 percentage points compared to 2024 [1] - The gross margin for instruments in overseas markets was significantly higher at 38.30% [1] - Despite a slowdown in reagent revenue growth due to domestic centralized procurement policies, the gross margin for both domestic and international reagents remained relatively stable due to optimized production costs and supply chain efficiency [1]